Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin 20 extended-regimen versus standard 24+4 regimen trial
2005-002125-32Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of drospirenone in contraception (3 arms), sponsored by Bayer. Primary endpoint: Total number of bleeding days during one year. Started Sep 2005; status: completed.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on 2005-002125-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002125-32.